SINGLETON J MATTHEW sold 68.6% of their position (20.79K shares) of VIKING THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.20M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 8/14/2024ACC: 0000950170-24-097325
Director
Since Jan 2019
-20.79K
Net shares
Net seller
$1.20M
Total sold
2
Open market trades
0B · 2S
4
Total transactions
20.79K acquired · 41.57K disposed
Non-Derivative Transactions3
Common Stock, par value $0.00001 per share
Direct
Shares
+20.79K
Price / share
$8.00
Trade value
$166.29K
% of position
218.8%
8/14/2024
9.50K→30.29K
Common Stock, par value $0.00001 per share
Direct
Shares
−20.63K
Price / share
$57.52
Trade value
$1.19M
% of position
68.1%
8/14/2024
30.29K→9.66K
Common Stock, par value $0.00001 per share
Direct
Shares
−160.00
Price / share
$58.37
Trade value
$9.34K
% of position
1.7%
8/14/2024
9.66K→9.50K
Total
Net shares
+0.00
Net value
-$1.03M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.00001 per share Direct | 8/14/2024 | M · Option Exercise | +20.79K | $8.00 | $166.29K | 218.8% | 9.50K | 30.29K |
| Common Stock, par value $0.00001 per share Direct | 8/14/2024 | S · Sale | −20.63K | $57.52 | $1.19M | 68.1% | 30.29K | 9.66K |
| Common Stock, par value $0.00001 per share Direct | 8/14/2024 | S · Sale | −160.00 | $58.37 | $9.34K | 1.7% | 9.66K | 9.50K |
| Total | +0.00 | -$1.03M | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
20.79K shares
Shares
−20.79K
Strike price
8.00
Held after
0.00
Exercisable
—
8/14/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock20.79K shares | 8/14/2024 | M · Option Exercise | −20.79K | 8.00 | — | 0.00 |